Patients with Chronic Lymphocytic Leukemia (CLL) are considered highly susceptible to bacteria and viruses due to immunocompromisation. Now, in the post-COVID era, we are facing multiple viruses at the same time (i.e., Influenza, RSV, and COVID). It is as important as ever for patients with CLL to continue receiving vaccinations, as well as following safety and preventive measures such as wearing masks and social distancing. CANCER BUZZ spoke to Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd, Co-Founder, Executive Vice President, and Chief Medical Officer at the CLL Society in Chula Vista, CA. Hear the most up-to-date best practices, including shared decision-making, regarding treating patients with CLL in this post-COVID era.
“The pandemic forced into the spotlight the reality that all CLL patients, regardless of their treatment status, even those who have not been treated, are immunocompromised. Patients had to make shifts in their lifestyle.”
“I think it is important that CLL patients realize that the pandemic is not over for the immunocompromised. And the virus that causes Covid infections, is not going away.”
– Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd
Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd
Co-Founder, Executive Vice President, and Chief Medical Officer
CLL Society
Chula Vista, CA
Resources:
Patients with CLL have a lower risk of death from COVID-19 in the Omicron era (nih.gov)
CLL Society
Cancer Support Community
ClinicalTrials.gov
Social Determinants of Health in Metastatic Breast Cancer
Overcoming Barriers to Holistic Survivorship Care for Immunotherapy Patients
Integrating Genetic Counselors in Routine Genitourinary Care
A Multidisciplinary Approach to Anemia Management in High-Risk MDS and AML
Improving Care Delivery to Patients Newly Diagnosed with Breast Cancer
Highlights from the ACCC Working Summit: Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education
Care Action Plans for People with Cancer
Beyond the Brush: Navigating Dental Care in Head & Neck Cancer
Navigating the Operational Challenges of Treatment with Bispecific Antibodies
Policy Perspectives on Biomarker Testing Coverage for 2024
Open Enrollment: Best Practices for End-of-Year Prep
Disparities in Accessing Care for AML Patients: Challenges and Solutions
Clarifying the Role of Maintenance Therapy
A Conversation With ACCC’s Outgoing and Incoming Presidents at the ACCC 50th Annual Meeting and Cancer Center Business Summit
LIVE from AMCCBS: White House Update
LIVE from AMCCBS: Capitol Hill Update
LIVE from AMCCBS: Institute for Comprehensive Cancer Care Services
LIVE from AMCCBS: New Payments for Patient Navigation
LIVE from AMCCBS: Financial Advocacy Resources
Making the Case for Head & Neck Cancer Patient Care Navigators
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain